Top Markets
Coin of the day
Dali Pharmaceuticalco.,Ltd Dali Pharmaceuticalco.,Ltd

Dali Pharmaceuticalco.,Ltd

603963
Pozycja w akcjach #27022
Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the... Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the research, development, manufacturing, and distribution of medicinal products. The company specializes in injectable medications, offering a diverse portfolio of both traditional Chinese and Western formulations. This includes 20 distinct drug varieties, with a total of 44 approved specifications. Key examples from their product line are Xingnaojing, Shenmai, Astragalus, Leucocin A, and Citicoline injections. Dali Pharmaceutical also maintains a substantial intellectual property collection, holding 31 patents comprised of 11 invention patents, 16 utility models, and 3 design patents. Established in 1996, the company operates from its headquarters located in Dali, China.
Cena akcji
$0.16240909
Ostatnia synchronizacja: 2025-03-04
Kapitalizacja rynkowa
$35.68M
Zmiana (1 dzień)
0.27%
Zmiana (1 rok)
0.00%
Kraj
CN
Handel Dali Pharmaceuticalco.,Ltd (603963)

Kategoria

EPS dla Dali Pharmaceuticalco.,Ltd (603963)
EPS na dzień September 2024 TTM: $-0.02
Według najnowszych raportów finansowych i ceny akcji firmy Dali Pharmaceuticalco.,Ltd, obecny EPS (TTM) wynosi $-0.02. Na koniec roku 2022 firma miała EPS w wysokości $-0.01, spadek w porównaniu do do EPS z roku 2021, który wynosił $-0.03.
Historia EPS dla Dali Pharmaceuticalco.,Ltd od 2012 do 2026
EPS na koniec każdego roku
Rok EPS Zmień
2026 (TTM) $-0.02 57.00%
2023 $-0.01 8.55%
2022 $-0.01 -60.87%
2021 $-0.03 -1,400.00%
2020 0.00 -73.86%
2019 $0.01 31.34%
2018 $0.01 -85.47%
2017 $0.05 -15.72%
2016 $0.05 -22.74%
2015 $0.07 -51.80%
2014 $0.15 6.06%
2013 $0.14 0.44%
2012 $0.14 0.00%
EPS dla podobnych firm lub konkurentów